Клінічний перебіг та ремоделювання лівого шлуночка в пацієнтів з гострим інфарктом міокарда з елевацією сегмента ST після первинного стентування коронарних артерій

 В.А. Скибчик, Ю.П. Мелень

Література   

  1. Farahani E, Saadat H. The Effect of percutaneous coronary intervention on isolated left ventricular diastolic dysfunction in patients with coronary artery disease assessed by using strain rate imaging. J Cardiol Clin Res. 2014;2(3):1037.
  2. Hashemi SR, Motamedi M, Khani M. et al. Evaluation of the effect of elective percutaneous coronary intervention as a treatment method on the left ventricular diastolic dysfunction in patients with coronary artery disease. J. Tehran University Heart Center. 2010;5(4):194-198.
  3. Iwanaga Y, Nishi I, Furuichi S. et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J. Am. Coll. Cardiol. 2006;47:742-748.
  4. Lagerqvist BHusted SKontny F. et al. Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006;16:998-1004.
  5. Naqvi TZ, Padmanabhan S, Rafii F. et al. Comparison of usefulness of left ventricular diastolic versus systolic function as a predictor of outcome following primary percutaneous coronary angioplasty for acute myocardial infarction. Am. J. Cardiol. 2014;97:160-166.
  6. Schannwell CM, Schneppenheim M, Plehn G. et al. Parameters of left ventricular diastolic function 48 hours after coronary angioplasty and stent implantation. J. Invasive Cardiol. 2003;15:326-333.
  7. Seok-Jae H, Vojtech M, Barry A. et al. Implications of coronary artery disease in heart failure with preserved ejection fraction (Mayo clinic). J. Amer. Coll. Cardiology. 2014;63:2817-2827. doi: 10.1016/j.jacc.2014.03.034.
  8. Spertus JAWinder JADewhurst TA. et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J. Am. Coll. Cardiol. 1995;25(2):333-341.
  9. Sahinarslan A, Cengel A, Okyay K. et al. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease. Cor. Art Dis. 2005;16:225-229.
  10. Morita E, Yasue H, Yoshimura M. et al. Increased plasma levels of brain natriuretic peptide concentrations in patients with acute myocardial infarction. Circulation. 1993;88:82-91.
  11. Olenchock BA, Wiviott SD, Murphys SA. et al. Lack of association between soluble CD40L and risk in large cohort patient with ACS in OPUS TIMI 16. J. Thromb. Thrombolysis. 2008;26(2):79-84.
  12. Seino Y, Ogawa A, Yamashita T. et al. Application of NT-proBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure. Eur. J. Heart Failure. 2004;6:295-300.
[PDF] [Зміст журналу]